The Wisconsin Society of Addiction Medicine hosts a monthly "Open Exchange" virtual series for discussion on issues affecting one's practice, patient care or the overall addiction medicine landscape. The teleconference calls serve as an open forum for members and non-members alike to informally interact with WISAM leaders.

Non-member clinicians may participate by signing up to receive call notifications. Let us know if you have a topic for future discussion!

Schedule of 2021 Open Exchange Calls (7:00-8:00 p.m. Central Time) -- subject to change

Thursday, January 28, 2021
Discussion Topics: 1) Experiences with Discharge of Patients on Agonist Therapy (methadone or buprenorphine) from the hospital to SNF and tricks on coordinating such discharges. 2) Discussion of Bupropion and Naltrexone in Methamphetamine Use Disorder article
Lead: Dr. Galbis-Reig, MD, DFASAM

Thursday, February 25, 2021
Discussion Topic: The elimination of the X-Waiver for physicians to prescribe buprenorphine, access to the COVID-19 vaccination and any other interests
Lead: Brian Lochen, MD, DFASAM

Thursday, March 25, 2021
Discussion Topic: Inpatient Addiction Consultative Services - Meeting the patient where they are at
Lead:  Charles Schauberger, MD, MS

Thursday, April 22, 2021
Discussion Topic: Case Presentation and Discussion: Severe GHB Use Disorder and Withdrawal Management
Lead: David Galbis-Reig, MD, DFASAM, Melissa Milne, APNP and  Jamie Frost, APNP

Thursday, May 27, 2021
Discussion Topic: Issues Specific to Treatment of Women with SUD
Lead: Ritu Bhatnagar, MD

Thursday, June 24, 2021
Discussion Topic: ASAM Criteria
Lead: Nameeta Dookeran, MD, FASAM

Thursday, July 22, 2021
Discussion Topic: InductionOLOGY - The Art of Buprenorphine Inductions in 2021
Lead: Alison Miller, DO

Thursday, August 26, 2021
Discussion Topic: "Harm Reduction Intervention on the Horizon: Overdose Prevention Sites" Review and Discussion of the Evidence
Lead: Elizabeth Salisbury-Afshar, MD, MPH, FAAFP, FACPM, DFASAM